The results in SHRs suggested that sodium ferulate protected against hypertension-induced cardiac hypertrophy by inhibiting the CaSR-mediated CaN-NFAT-3 signaling pathway [57]. This evidence concerns the gene CASR and cardiac hypertrophy.